Bonds Biosystems

🚀 Automation in Action!

Take a look at our liquid handler system in action—pipetting with precision into a 96-well plate. At BondsBio, we’re pushing the boundaries of 3D model manufacturing. With automation at the core of our process, we ensure:

✅ More Homogeneity
✅ More Reproducibility
✅ Better Results

This level of precision accelerates drug discovery and elevates research outcomes. We believe the future of biotech lies in scalable, high-quality models—and we’re making it happen!

💬 Curious how automation impacts your research? Let’s discuss in the comments! How do you see automation transforming the future of biotech?

As part of the -LAB community, Bonds Biosystems support and strongly recommend you to connect with Kaufman , Nir and all the ABI-LAB team.

Natick is a terrific place to have your startup and ABI-LAB facilities are simply incredible. A innovation center full of high-tech equipments and goods are available to all tenants and you will find more than 40 highly skilled and enthusiastic biotech companies looking for new partnerships and business.

Talk to them and enjoy

Bonds Biosystems on LinkedIn: BIO International Convention | June 5-8, 2023 | Boston, MA As part of the ABI-LAB community, Bonds Biosystems support and strongly recommend you to connect with Gary Kaufman , Raphael Nir and all the ABI-LAB…

Today Bonds Biosystems attended the Boehringer Ingelheim Transforming Science Day at MassBio HUB.

We feel entirely inspired by BI’s Vision centering patients and working diligently to find the best hits to bring new hopes to humankind.

BI showed, among other exciting achievements, how they work integrating platforms to find the best targets and then the first-in-class solutions to the most challenging human diseases and that small-market drugs and diseases are also their priority.

Finally, they gave a beautiful color to one of the pillars of BI’s “flower,” the willingness to collaborate/partner with emerging biotechs, startups, and academic labs toward the best targets and treatments for patients.

Bonds Biosystems is pleased to have been there today.

At Bonds Biosystems, we are making human mini-organs mainstream.

If you want to visit our lab facility at ABI-LAB in Natick, MA, contact us at [email protected].

It is a great pleasure to have you in our house.
Enjoy your weekend.

NOW, we are also on Instagram!!!

Follow our social media and visit our website at http://bondsbio.com

LinkedIn: https://www.linkedin.com/company/bondsbio/
Twitter: https://twitter.com/BiosystemsBonds
YouTube: https://www.youtube.com/channel/UCsqMd7WpFEsVdogxVZeb9iw

Bonds Biosystems, making human mini-organs mainstream

Join us in the 3D revolution!!!

ABI-LAB SBH Sciences Raphael Nir

Miguel Luiz Batista Junior
Rafael Dariolli
Sal Diaz-Bazan

Today we want to share with you how Bonds Biosystems will help you.

As a flexible company, we are focused on learning about your pains so that we can help you solve them with our products (solutions) and services (services). On our brand-new website, you will find information about our standard platforms, products, and services, but keep in mind that we are a flexible team.

Our team is available via multiple channels to assist you with your needs. In essence, Bonds Bio is the dream of scientists that value quality science, so together we can find a solution that will solve your pains.

Tomorrow a quick tour of the new website.

Enjoy your Sunday!

3D BioSol™ Human Obesity models

Advanced 3D models for metabolic disease and drug testing

Designed for investigating cardiometabolic diseases' pathophysiology, adipocyte remodeling, insulin resistance, and lipolysis dysfunction and screening new anti-obesity drugs, the 3D BioSol™ AT Obesity Platform is an ideal tool for investigating cardiometabolic diseases, from efficacy to safety. Our innovative 3D cell-based technology enables disease-tunable 3D adipose tissue models derived from different depots (visceral, subcutaneous, and breast) and brings the power of the 3D BioSol™ Heart platform to the forefront to guarantee your novel treatments' safety.

Hold tight, Tuesday is fast approaching, and you will find more information on our brand-new website. Keep up with us on LinkedIn until then.

Have a wonderful Saturday.

Enhance your drug efficacy and safety testing with 3D BioSol™

Bonds Biosystems collaborates with representatives from the pharmaceutical, life science (academy and other companies), and regulatory communities to develop standards and protocols for using advanced 3D models and technology platforms for drug discovery, development, and disease modeling.

By investing in 3D BioSol™ discovery and safety platforms, you will have access to our 3D BioSol™ mini-organs, specially formulated media kits, rigorously tested disease inducer protocols, optimized technical methods and procedures, and expert support services.

Designed to Improve Science

Using our 3D BioSol™ Process, mini-organs are physiologically relevant and uniform in quality. We create models suitable for 3D optimization using proprietary techniques, media formulations, and innovative tissue engineering approaches.

No matter what type of 3D culture plate or system you use, we can tailor our models to your needs.

Our flexible services will accelerate your sourcing, development, production, and quality control processes. Consequently, you will be able to make better and faster decisions about your compounds.

Let's talk about where Bonds Bio solutions can be applied tomorrow.
See you then!